Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Frontiers in Oncology|March 27, 2020
Cisplatin Resistance in Osteosarcoma: <i>In vitro</i> Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored TreatmentsMarilù Fanelli, Elisa Tavanti, Maria Pia Patrizio, et al.
European Journal of Cell Biology|November 16, 2004
Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of boneClaudia Maria Hattinger, Maija Tarkkanen, Stefania Benini, et al.
Genes, Chromosomes & Cancer|January 22, 2011
Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of boneTarja Niini, Leo Lahti, Francesca Michelacci, et al.
Cancer|March 29, 2002
Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donorsFernanda Martini, Lorena Lazzarin, Laura Iaccheri, et al.
Histopathology|January 21, 2015
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapyClaudia Maria Hattinger, Francesca Michelacci, Federica Sella, et al.
Oncology Reports|May 13, 2004
Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cellsTokuhiro Chano, Kanji Mori, Katia Scotlandi, et al.
International Journal of Molecular Sciences|January 8, 2023
Strategies to Overcome Resistance to Immune-Based Therapies in OsteosarcomaClaudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cellsS Benini, M C Manara, N Baldini, et al.
Chemmedchem|September 5, 2008
A potent integrin antagonist from a small library of cyclic RGD pentapeptide mimics including benzyl-substituted azabicycloalkane amino acidsDaniela Arosio, Laura Belvisi, Lino Colombo, et al.
Oncogene|April 13, 2005
In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell typeStefania Benini, Bernard Perbal, Diana Zambelli, et al.
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|March 27, 2020
Cisplatin Resistance in Osteosarcoma: <i>In vitro</i> Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored TreatmentsMarilù Fanelli, Elisa Tavanti, Maria Pia Patrizio, et al.
European Journal of Cell Biology|November 16, 2004
Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of boneClaudia Maria Hattinger, Maija Tarkkanen, Stefania Benini, et al.
Genes, Chromosomes & Cancer|January 22, 2011
Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of boneTarja Niini, Leo Lahti, Francesca Michelacci, et al.
Cancer|March 29, 2002
Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donorsFernanda Martini, Lorena Lazzarin, Laura Iaccheri, et al.
Histopathology|January 21, 2015
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapyClaudia Maria Hattinger, Francesca Michelacci, Federica Sella, et al.
Oncology Reports|May 13, 2004
Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cellsTokuhiro Chano, Kanji Mori, Katia Scotlandi, et al.
International Journal of Molecular Sciences|January 8, 2023
Strategies to Overcome Resistance to Immune-Based Therapies in OsteosarcomaClaudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cellsS Benini, M C Manara, N Baldini, et al.
Chemmedchem|September 5, 2008
A potent integrin antagonist from a small library of cyclic RGD pentapeptide mimics including benzyl-substituted azabicycloalkane amino acidsDaniela Arosio, Laura Belvisi, Lino Colombo, et al.
Oncogene|April 13, 2005
In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell typeStefania Benini, Bernard Perbal, Diana Zambelli, et al.
Pageof 16